Insider sales are immaterial in dollar terms and likely reflect routine diversification and option exercise tax planning. No bearish signal from this cluster.
MIRM drugs
MIRM drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 10 $94.00entry
- T+1 · 5mo ago +5.89%α +4.19% · $99.54
- T+5 · 5mo ago +8.03%α +4.60% · $101.55
- T+20 · 4mo ago +35.85%α +32.23% · $127.70
- T+60 · 2mo ago +7.05%α +0.47% · $100.63
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three Mirum insiders, including the CEO and CFO, sold a total of $854K in open-market sales over a one-week window. The CFO also exercised and sold shares from option exercises, while the COO exercised options without selling. The sales represent ~0.015% of the $5.7B market cap, well below the 0.1% threshold for materiality, and the cluster includes a mix of cashless exercises and open-market sales, suggesting routine portfolio management rather than a coordinated bearish signal.
Key Financial Metrics
Key Facts
- CEO Christopher Peetz sold 2.6K shares for $246K on 2026-06-01
- Director Saira Ramasastry sold 4.0K shares for $398K on 2026-06-01
- CFO Eric Bjerklolt sold 2.3K shares for $210K on 2026-06-08, following option exercises
- Total open-market sales: $854K, representing ~0.015% of market cap
- COO Peter Radovich exercised 16,988 options on 2026-06-05 but did not sell any shares
Financial Impact
Total insider sales of $854K, or ~0.015% of $5.7B market cap, trivial relative to company size
Risk Factors
- Insider sales, while small, could be misinterpreted by retail traders as a negative signal
- The CEO and CFO both sold, which may raise questions if followed by larger sales
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-MIRM-1781054493725 |
Track record
27 reports on MIRM
5 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +28.29% at T+20 after the Jun 11, 2026 report. 8 of 10 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $92.28 Now $91.58 −0.76% settles Feb 12
- Nov 13, 20263d ago Insider Cluster Neutral 3/10 Entry $93.54 Now $91.58 −2.10% settles Feb 12
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $93.33 Now $91.58 −1.88% settles Feb 10
- Nov 10, 20266d ago 8-K Bullish 6/10 Entry $94.42 Now $91.58 −3.01% settles Feb 8
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $93.54 Now $91.58 −2.10% settles Feb 3
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $93.54 Now $91.58 −2.10% settles Feb 3
- Nov 3, 202613d ago 8-K Bullish 6/10 Entry $96.97 Now $91.58 −5.56% settles Feb 2
- Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $85.81 Now $91.58 +6.72% settles Jan 26
- Oct 26, 202621d ago 8-K Bullish 6/10 Entry $85.56 Now $91.58 +7.04% settles Jan 25
- Oct 13, 20264w ago 8-K Bullish 7/10 Entry $79.62 Now $91.58 +15.02% settles Jan 8
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers